Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

50%(2 trials)

Phase Distribution

Ph phase_1

40%

Ph phase_4

20%

Ph not_applicable

20%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

2(40.0%)

Phase 2Efficacy & side effects

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (40.0%)

Phase 21 (20.0%)

Phase 41 (20.0%)

N/A1 (20.0%)

Trials by Status

completed480%

withdrawn120%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_1

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis

NCT01422954

Clinical Trials (5)

Showing 5 of 5 trials

NCT04866602Phase 1

Atoguanil BA Study

Completed

NCT03991208Phase 4

Malarone Pharmacokinetics Under Simulated Physiologic Stressors of Deployment

Withdrawn

NCT02450578Phase 1

DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria

Completed

NCT00298610Phase 2

Safety and Efficacy Study of IV Artesunate to Treat Malaria

Completed

NCT01422954Not Applicable

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5